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Abstract
The known functions of the human GCOM1 complex hub gene include transcription elongation 
and the intercalated disk of cardiac myocytes. However, in all likelihood, the gene's most 
interesting, and thus far least understood, roles will be found in the central nervous system. To 
investigate the functions of the GCOM1 gene in the CNS, we have cloned human and rat brain 
cDNAs encoding novel, 105 kDa GCOM1 combined (Gcom) proteins, designated Gcom15, and 
identified a new group of GCOM1 interacting genes, termed Gints, from yeast two-hybrid (Y2H) 
screens. We showed that Gcom15 interacts with the NR1 subunit of the NMDA receptor by co-
expression in heterologous cells, in which we observed bi-directional co-immunoprecipitation of 
human Gcom15 and murine NR1. Our Y2H screens revealed 27 novel GCOM1 interacting genes, 
many of which are synaptic proteins and/or play roles in neurologic diseases. Finally, we showed, 
using rat brain protein preparations, that the Gint internexin-alpha (INA), a known interactor of the 
NMDAR, co-IPs with GCOM1 proteins, suggesting a GCOM1-GRIN1-INA interaction and a 
novel pathway that may be relevant to neuroprotection.
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1. Introduction
The human GCOM1 gene (original gene symbol, GRINL1A) produces three sets of 
transcripts and proteins from two neighboring genes transcribed in the same direction on the 
long arm of chromosome 15 by a mechanism we termed the complex transcription unit 
(CTU) (Roginski et al., 2001; Roginski et al., 2004). Since our discovery and description of 
its genomic organization (Roginski et al., 2004), many ground-breaking findings have 
emerged from studies on the upstream (centromeric) gene, which generates the Gup 
transcripts and proteins, as well as from the downstream (telomeric) gene, which produces 
the Gdown transcripts and proteins. The individual components of the CTU were therefore 
assigned the gene symbols MYZAP for Gup1 and POLR2M for Gdown1.
Significant functions have been identified for the genes that produce the Gup1 and Gdown1 
proteins. POLR2M encodes Gdown1, which was recognized as the 13th subunit of RNA 
polymerase II in 2006 (Hu et al., 2006), a seminal finding in the field of transcription which 
has subsequently been investigated in at least two major laboratories. Gdown1 performs 
essential functions in regulating transcription elongation (Cheng et al., 2012; Jishage et al., 
2012). MYZAP codes for the Gup1 protein, aka Myozap (Seeger et al., 2010), which plays a 
vital role in the intercalated disk of cardiac myocytes, cell–cell adhesions in stable tissues 
and cell migration during tissue development and remodeling (Huo et al., 2011). Knock-out 
of Gup1 in zebrafish results in cardiomyopathy (Seeger et al., 2010).
We have focused our research on the GCOM1 combined (Gcom) proteins, whose 
predominant expression occurs in the CNS, because these proteins may play roles in 
neuroprotection, neuropsychiatric and neurodegenerative diseases. In our prior work on the 
GCOM1 gene, we cloned a 550 amino acid ORF from human adult brain mRNA (Roginski 
et al., 2004) and subsequently identified a corresponding 64 kDa protein, named Gcom1, for 
GCOM1 combined protein 1, in rat brain (Roginski et al., 2008). Gcom1 was detected with 
antibodies raised against a synthetic peptide corresponding to amino terminal residues S23-
E38. As expected, these antibodies also revealed the predicted 54 kDa Gup1 protein (466 
aa), which shares many amino terminal exons with Gcom1. Surprisingly, this antibody 
preparation also reacted with a novel, larger, putative GCOM1 protein migrating as a 105 
kDa band, which was provisionally named Gcom15 (Roginski et al., 2008). Gcom15 was 
not predicted based upon the GCOM1 transcripts we cloned as of 2008. Such a protein could 
be highly significant, because our co-immunoprecipitation experiments with anti-GCOM1 
antibodies showed co-IP with the rat NMDA receptor subunit 1 (NR1; human gene symbol 
GRIN1) in rat brain protein preparations. Furthermore, we demonstrated that anti-GCOM1 
antibodies protected rat cortical neuronal cultures against NMDA toxicity, implying that a 
GCOM1 protein may be involved in a novel, neuroprotective cascade. However, these 
experiments did not reveal which GCOM1 protein(s) were responsible for the pull-down of 
the NMDAR subunit (Roginski et al., 2008). The most likely candidates would be Gcom1 
and the novel Gcom15.
Therefore, we sought to isolate mRNAs/cDNAs capable of generating the larger protein with 
the goals of determining its size using heterologous cell expression and performing co-IP 
with co-expressed NR1 subunits to provide further evidence for the interaction with the 
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NMDAR observed in rat brain. At the same time, we carried out yeast two-hybrid screens to 
search for genes capable of interacting with Gcom1, because additional mediators would be 
needed to explain the neuroprotective effect. Here we describe our isolation and 
characterization of Gcom15 clones from human and rat sources, expression and co-
immunoprecipitation of Gcom15 and NR1 subunits in heterologous cells, yeast two-hybrid 
screens using Gcom1 cDNA clones as bait, and immunologic experiments to confirm one of 
these Y2H interactions, with the neuronal intermediate filament gene, internexin-α (gene 
symbol INA), in a mammalian system. Our results suggest an interaction or interactions 
among three genes, GCOM1, GRIN1 and INA, that may activate a new pathway relevant to 
normal CNS function and neurologic disease.
2. Materials and methods
2.1. Cloning of Gcom1 and Gcom15 cDNAs
Human GRINL1A combined transcript 1 (Gcom1) cDNA was cloned using a single-tube 
reverse transcriptase PCR procedure, as previously described (Roginski et al., 2008). Human 
and rat Gcom15 cDNAs were cloned from adult brain mRNA as overlapping 5′ and 3′ 
segments using the Titan RT PCR system (Roche; Indianapolis, IN). The overlapping 
segments were combined by hybridization-extension PCR. The resulting large amplicons 
were ligated and transformed into competent E. coli using the TOPO-TA vector system 
(Invitrogen; Carlsbad, CA). Plasmid DNA aliquots from positive colonies were sequenced 
revealing intact open reading frames (ORFs) coding for 765 and 761 amino acids for human 
and rat Gcom15 respectively. The inserts were subcloned into the pCIneo expression vector 
(Promega; Madison, WI).
2.2. Bioinformatic analyses
Identities of the Gcom1 interacting cDNA clones (Gints) were determined by NCBI BLAST. 
Participation in biological networks was assessed by Ingenuity Pathways Analysis 
(Ingenuity Systems, Redwood City, CA) software and other bioinformatics tools available 
on the internet such as the European Bioinformatics Institute and GeneCards. Interactors of 
Gcom1 from the Y2H experiment were analyzed by placement of the molecules in networks. 
Interaction networks of Gcom1 and its interactors were developed according to the 
likelihood of occurrence in vivo. The networks were then given a numerical value score 
based on the hypergeometric distribution, to rank the networks to determine the degree of 
relevance. Networks with the highest scores were recorded and analyzed to determine their 
relevance to neurologic disease, neurologic and other functions.
2.3. Transfection, protein isolation, immunoprecipitation and Western blotting
Each Gcom15 cDNA (0.5 μg) was transfected into HEK293 cells with or without the mouse 
NR1-1a NMDAR subunit in pcDNA3 and incubated for 24 h at 37 °C. Membrane plus 
cytosolic proteins were isolated from transfected cells for both Western blots and 
immunoprecipitation (IP) experiments with anti-GCOM1 Ab against residues S23-E38 
(GenScript order ID 416739, chickens 602 and 604) and T423–Q440 (GenScript ID 109531, 
rabbits 1585 and 1586) or with anti-NR1 Ab. After determining protein concentration in the 
sample with the BCA protein assay (BioRad), 100 μg of both membrane and cytosolic 
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proteins were transferred to a total of 6 microcentrifuge tubes (600 μg total protein). The 
lysate was precleared by adding 20 μL of Protein A-agarose (Invitrogen) and shaken for 30 
min at 4 °C. The lysate was centrifuged to pellet the beads at 12,400 rpm for 15 min at 4 °C. 
After transferring the supernatant to new tubes, 2 μg of anti-Gcom1 T423-Q423 primary 
antibody were added to 2 tubes, 2 μg of anti-NR1 antibody (mouse monoclonal, BD; goat 
polyclonal, Santa Cruz) were added to 2 tubes and 2 tubes were given 2 μg of IgG instead of 
specific antibody. All tubes were incubated for 2 h on a rocker at 4 °C. After incubation, 40 
μL of Protein-A agarose was added to the tubes followed by incubation at 4 °C on a rocker 
overnight (14–18 h). Each tube was then centrifuged at 12,400 rpm for 15 min at 4 °C. The 
supernatant was aspirated, and the beads were washed again two more times. After the final 
wash, tubes were centrifuged for 15 min at 12,400 rpm, the supernatant was aspirated, and 
40 μL of 4× concentrated sample buffer was added to each tube. The beads were boiled for 
10 min to elute proteins and finally centrifuged at 12,400 rpm for 15 min. The supernatant 
from each tube was then loaded into a 12% SDS-PAGE Bis-Tris gel in 1× SDS PAGE 
running buffer for 90 min at 120 V. The gel was placed in 1× transfer buffer (20% methanol 
in running buffer without SDS). A gel sized piece of polyvinyldifluoride (PVDF) was placed 
in 100% methanol and then on top of gel in between Brillo pads and Whatman leaves. Gel 
and PVDF complex was placed in transfer box and run at 100 V for 1 h in 4 °C. After PVDF 
was rinsed in 1× PBS (phosphate buffered saline, pH 7.4), PVDF was stained with Ponceau 
S to visualize protein, and then destained. After PBS rinses, PVDF was stored overnight in 
blocking buffer (1% BSA and 5% non-fat dry milk in 0.05% Tween-20 in 1× PBS). The 
membrane was then cut into 2 pieces; one for the anti-Gcom1 and the other for anti-NR1 Ab. 
Each membrane piece was then placed in primary antibody in blocking buffer (1:500 for 
anti-NR1, 1:1000 for anti-Gcom1) for 2 h at 20 °C. PVDF membranes were rinsed in 0.1% 
Tween in 1× PBS and then immersed in anti-rabbit secondary horseradish peroxidase 
(1:10,000; Amersham, Piscataway, NJ) for 1 h at 20 °C. After washes with 0.1% Tween in 
PBS, secondary antibodies were visualized with chemiluminescent detection (Figs. 3 and 6) 
using a Chemiluminescence kit (Amersham). ECL solution was placed on membranes in a 
dark room. Membranes were placed in developing cassette and X-ray photos were taken at 
varying exposure times.
For the experiments in Fig. 5 (and other experiments, not shown), rat brain samples were 
derived from humanely euthanized white adult male Wistar rats. Brains (hemispheres) were 
either removed and immersed in liquid nitrogen or were removed after perfusion with cold 
saline and stored at −80 °C. Rat brain tissue was homogenized in a buffer of 0.32 M sucrose, 
20 mM Tris–HCl (pH 7.5), 1 mM EDTA, 1 mM PMSF, 1 μL/mL protease inhibitor cocktail 
(P-8304, Sigma) and then centrifuged at 1000 ×g for 15 min. The supernatant was collected 
and centrifuged at 100,000 ×g for 60 min; the supernatant was again collected. The pellet 
was washed and resuspended with lysis buffer (20 mM Tris–HCl (pH 7.5), 1 mM EDTA, 1 
mM PMSF, 1 μL/mL protease inhibitor cocktail). The final precipitate and the supernatant, 
containing cellular and membrane proteins, were collected and stored separately at –80 °C. 
Membrane and cytosolic proteins were then isolated from the cell supernatant using a 
Plasma Membrane Protein Extraction Kit (MBL International; Woburn, MA). Also in Fig. 5, 
we used the Odyssey protocol (Li-Cor) for detection of fluorescently labeled secondary 
antibodies. For immunoprecipitations, 8 μg of anti-GCOM1 T423-Q440 (rabbit 1586) 
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antibody was added to 400 μg rat brain proteins (RBP) followed by precipitation overnight 
at 4 °C. On the next day, 1.5 mg Dynabeads Protein G (Novex, catalog # 10003D) was 
added to the IP mixture; 1.5 mg Dynabeads is an excess to bind immune complexes from 
these amounts of Ab/protein. The unbound fraction (flow-through) from the Dynabeads-Ab-
Ag complexes (pellet) was retained for Western blot analysis. As a negative control, 400 μg 
RBP were immunoprecipitated with anti-synaptophysin Ab (Millipore, MAB329). Each 
sample well of the WB was loaded with 25% (by volume, equivalent to the IP complexes 
from 100 μg of RBP) of the material eluted from the Dynabeads. (Due to the small amounts 
of protein in the immune complexes, it is impractical to quantitate the amounts loaded into 
the gel.) Each IP was carried out at least three times with the same results as shown in Fig. 5.
2.4. Yeast two-hybrid screening
Amino (codons 22–414; plasmid G113D) and carboxy (332–550; plasmid G923C) cDNA 
segments of the human Gcom1 mRNA/protein were cloned into the Yeast Two Hybrid 
(Y2H) vector pCWX200 and screened using a TetR system against an adult human brain 
cDNA library (ProteinLinks; San Diego, CA). The N- and C-terminal screens yielded 11 and 
48 verified clones, respectively, which were amplified using E. coli transformation, PCR or 
both and sequenced.
3. Results
3.1. Cloning, sequence and structural features of Gcom15
The most parsimonious hypothesis to explain Gcom15 is to splice exon 21a between exons 
13 and 22 of the Gcom1 cDNA sequence (Table 1). In the human genome, the addition of 
exon 21a (645 bases) predicts a 765 aa ORF, while in rat, a 761 aa ORF would arise because 
rat has a shorter exon 21 (633 bases). To verify these ORFs, adult human and rat brain 
mRNA samples were amplified by RT PCR with two sets of primers designed to generate 
long, overlapping upstream and downstream products from the predicted Gcom15 mRNAs. 
The human products were mixed, heated to separate the strands, self-annealed and extended 
for several cycles, followed by amplification with a pair of nested primers located in the 5′ 
and 3′ untranslated regions of the human ORF. This strategy, which we call hybridization-
extension PCR, is illustrated in Fig. 1A. The resulting 2.3 kb amplicon contained the entire 
human Gcom15 coding region (Fig. 1B, lane 1). Restriction endonuclease digestion and 
DNA sequencing of the cloned insert revealed intact reading frames with the splicing 
patterns shown in Table 1. The cloned human Gcom15 ORF was excised, inserted into the 
expression vector pCIneo and sequenced again to confirm the integrity of the ORF. For the 
rat Gcom15 ORF, cloning of upstream and downstream products resulted in plasmids having 
orientations amenable to direct (i.e., without PCR amplification) reconstitution of the entire 
rat Gcom15 reading frame by utilizing the unique HpaI restriction site. The exon structures 
of the human Gcom1 and Gcom15 cDNAs and proteins are shown in Fig. 2A. The cloned 
human and rat Gcom15 ORFs predict 765 and 761 amino acid proteins, respectively, with 
unmodified masses of 87.8 and 86.9 kDa (Table 1).
Homology searches revealed that the Gcom15 proteins are not orthologs or paralogs of any 
known gene. However, identity and similarity comparisons (e.g., Bestfit and similar 
Roginski et al. Page 5
Gene. Author manuscript; available in PMC 2018 June 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
programs) using the human Gcom15 sequence revealed results similar to those we reported 
previously for Gcom1 (Roginski et al., 2004). Briefly, the Gcom1 and Gcom15 proteins 
display similarity to several proteins that interact with the NR1 subunit (human gene symbol 
GRIN1) of the NMDA receptor (NMDAR). Chief among these are the NR2A and NR2B 
NMDAR subunits (human gene symbols GRIN2A and GRIN2B); the rat NR3A subunit; and 
yotiao [gene symbol AKAP9 (Lin et al., 1998)]. In the interval since our 2004 publication, 
we have found additional GRIN1-interacting proteins that display similarity to the Gcom1/
Gcom15 amino acid sequences (Supplementary Table 1): kalirin-7 (KALRN); α-actinin 
(ACTN1); neurofilament-L (NEFL); and internexin-α (INA). To assess whether the Gcom1/
Gcom15 sequence similarities were restricted to genes that interact with the GRIN1 subunit, 
three genes known to interact with the NR2 subunit genes GRIN2A and B were compared 
with the large GCOM1 proteins by the same method: SAP102 (gene symbol DLG3), PSD95 
(DLG4) and nNOS (NOS1) did not show similarity to Gcom1. Finally, NCBI homology 
searching using the stringent software blastp (run date 1 Sep 2015) revealed one gene that 
exceeded the significance threshold (E-value 4.47 e–03): lebercilin (gene symbol LCA5), a 
ciliary protein involved in Leber congenital amaurosis 5 and severe early-childhood-onset 
retinal dystrophy (Dharmaraj et al., 2000). Lebercilin displayed a 194 aa overlap of its 
amino terminal residues 11–193 with amino terminal residues 126–312 of human Gcom15. 
This alignment scored 24.2% identity and 44.8% similarity. Interestingly, one of the four 
interacting genes for LCA5 listed in GeneCards is the GRIN2B subunit, another suggestive 
link to the NMDAR. Taken together, identity and similarity comparisons suggest that 
Gcom15's amino acid sequence resembles extensive segments of proteins that interact with 
the GRIN1 subunit of the NMDAR. However, no significant similarity was detected between 
Gcom1 and several proteins that interact with GRIN2 subunits, suggesting that a possible 
GCOM1-GRIN1 interaction may be more likely than with GRIN2 subunits. Next, several of 
the genes showing similarity to Gcom1/Gcom15 have been implicated in neurologic 
diseases. Finally, GeneCards lists one Gene Ontology biological process in the GCOM1 
entry: intracellular signal transduction.
The primary sequences of the human and rat Gcom15 proteins contain features characteristic 
of type 1 membrane proteins. First, visual inspection of Gcom15's amino terminal residues 
and the output files from the programs Signal P-4.1 (run dates 18 May 2014 and 27 June 
2015 for the human and rat sequences respectively) and Phobius (run dates 20 and 27 June 
2015) predict a preferred signal peptide cleavage site between residues 16 and 17, with a 
possible secondary site at 20/21 (only in Signal P). In both sequences, the N-region covers 
residues 1–3; the H-region corresponds to 4–11; and the C-region comprises residues 12–16. 
Second, the key features of the Gcom15 amino acid sequence are the same as we originally 
reported for the Gcom1 sequence (Roginski et al., 2004). However, due to the presence in 
human Gcom15 of exon 21a, there are two additional consensus N-linked glycosylation sites 
compared with human Gcom1, which has only one such site, in exon 22. (Note that the exon 
22 site is not conserved in rat exon 22.) All 3 consensus N-glycation sites in human Gcom15 
(at residues 609, 614 and 656) are located amino to the putative membrane spanning region 
(MSR; amino acids 685–703). The presence of glycosyl moieties at one or more of the 
consensus sites would strongly favor an extracellular destination for the long amino 
terminus. Rat Gcom15 conserves only the first consensus N-glycosylation site (at N605, 
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which corresponds to N609 of human Gcom15). Next, the residues bracketing the putative 
MSR, DD683–684 and EE704–705 in human Gcom15, are the same in both species. The 
amino acids of the MSR, I685–I703 in the human sequence, are highly conserved in both 
species. Finally, both Gcom15 sequences contain the identical, consensus endoplasmic 
reticulum retention-retrieval sequence in their carboxy termini, RYR, which are amino acids 
749–751 in the human ortholog.
Secondary and tertiary structure predictions of the human Gcom15 sequence using the Phyre 
software also are consistent with a type 1 membrane protein. Residues 1–40 display coiled 
coil and α-helical segments; 41–489 are α-helix; 490–593 are coiled coil and α-helix; 594–
670 (containing three N-glycosylation sites in human Gcom15) have no consensus; residues 
671–730 (which include the putative MSR) display coiled coil and α-helix structure; and 
finally 731–764 (part of the putative intracellular segment) show coiled coil and beta sheet. 
According to the ProtParam tool (ExPASy software; run date 20 Nov 2014), human Gcom15 
has instability index of 58.48, and rat Gcom15's index is 58.95, both of which classify these 
proteins as “unstable.” Phyre predicts structural overlap with smooth muscle heavy chain 
(MYH11) with an E-value of 4.2 × e−35 and a 6% identity overlap. Amazingly, three 
interactors of MYH11 in GeneCards are GRIN1, GRIN2A and GRIN2B. Therefore, 
MYH11 is another instance of a protein with similarity to Gcom15 which interacts with 
NMDAR subunits. A space-filling model of human Gcom15, which incorporates the 
predicted secondary structure features, is depicted in Fig. 2B. The large amino terminus 
connects to the smaller, putative intracellular carboxyl end by several extended segments, 
which include the predicted MSR. Finally, Western blots of rat brain protein fractions 
stained with anti-amino and anti-T423-Q440 antibodies revealed significant amounts of rat 
Gcom15 in the plasma membrane fraction (results not shown).
3.2. Expression of Gcom15 proteins in heterologous cells
Each Gcom15 cDNA was transfected into HEK293 cells with or without the mouse NR1-1a 
NMDAR subunit cDNA. Western blots of membrane proteins isolated from transfected cells 
revealed 105 kDa bands when stained with anti-GCOM1 Ab (Fig. 3A, B, top panels). Co-
transfection of human or rat Gcom15 cDNA with mouse NR1-1a cDNA revealed co-IP of 
NR1 protein by anti-GCOM1 Ab (Fig. 3A, lower panels). The “reverse” co-IP, using anti-
NR1 antibodies, revealed co-IP of the human (but not rat) Gcom15 (Fig. 3B, lower panels). 
The likelihood that GCOM1-GRIN1 PPIs play a role in neuroprotection, as shown in our 
previous work (Roginski et al., 2008), implies that GCOM1 proteins interact with other 
proteins besides the NR1 subunit. Therefore, we searched for additional GCOM1-interacting 
genes.
3.3. Yeast two-hybrid (Y2H) studies
We screened an adult human brain cDNA library with the 550 aa human Gcom1 cDNA 
(AY207007) to find additional candidate interacting genes. The Gcom1 sequence was 
chosen primarily because it was the largest GCOM1 cDNA available prior to the cloning of 
the Gcom15 cDNAs and should detect more interacting genes than the smaller Gdown1 and 
Gup1 cDNAs. Second, the combined proteins are a distinguishing feature of the GCOM1 
gene, and none had been screened for interacting partners prior to our study.
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3.4. Rationale for design of Gcom1 bait clones
Because Gcom1 cDNA has a larger ORF than typical Y2H clones, it was engineered into 2 
smaller, overlapping amino- and carboxy-terminal clones. A second issue was that the 
Gcom1 protein begins with a candidate signal peptide (residues 1–16), a sequence that might 
cause the hybrid protein to bind with yeast membranes and prevent its transit to the nucleus. 
If these residues were to be included in the amino-terminal bait clone, they might limit the 
detection of interacting genes, and could also lead to a false negative result when tested in 
the bait self-activation control. Therefore, we chose cDNA segments that spanned codons 
22–414 and 332–550. Finally, the overlapping design also allowed us to test the hypothesis 
that one or more interacting clones would occur in both screens, thereby potentially 
localizing the interaction of such clones to residues 332–414.
3.5. Identities of Y2H Gcom1 interacting genes (Gints)
The COOH and NH2 screens identified and confirmed 48 and 11 clones, respectively 
(Supplementary Data, Supplementary Table 2A and B). Plasmid DNA minipreps of prey 
clones were sequenced and identified by BLAST searches. Several prey clones occurred 
more than once, such that the 59 clones represented 27 unique gene symbols. Three genes, 
internexin-α (INA), MIF and PDE4DIP, were revealed in both screens, suggesting that these 
proteins may interact preferentially with Gcom1 amino acids 332–414, which are derived 
from exons 9/10/12/13 and have the same residue numbers in human Gcom15. INA was the 
most frequently observed gene symbol, occurring twice in the amino screen and 7 times in 
the carboxy screen (9 total hits).
3.6. Chromosome sites of GCOM1 interacting genes
The human chromosomal locations of our Y2H Gints, shown in Table 2, reveal no obvious, 
genome-wide pattern. However, the distribution of Gints does not appear to be completely 
random, in that several chromosomes contain multiple Gints, especially chromosomes 1 and 
11, which have 5 and 3 Gints, respectively, and may hint at functional significance. 
Furthermore, it is intriguing that several pairs of Gints reside on the same chromosome arm, 
relatively close to each other. On chromosome 1, DLGAP3 and KCNAB2 lie at bands 1p34 
and 1p36, respectively; PDE4DIP and RIIAD1 are less than 300 kb apart at 1q21.2 and 
1q21.3, respectively. On chromosome 11, FTH1 and FAM89B reside at 11q12.3 and 
11q13.1, respectively.
An even more interesting cluster of 4 genes, which may provide insights into the functions 
of GCOM1, occurs at chromosome 9q34.3: the Y2H Gint olfactomedin 1 (OLFM1), the 
neurodevelopmental hub gene NOTCH1, the immunologically determined Gint GRIN1 and 
the IPA Gint NSMF (see Fig. 4) all reside in a 2 Mb segment between bases 135,075,243 
(start of OLFM1; GeneCards accessed 4 September 2016) and 137,459,357 (end of NSMF). 
Several genes proximal to human GCOM1 on chromosome 15q21.3/q22.1 may also shed 
light on the roles of GCOM1 as well as the complex gene model (see Discussion, Section 
4.4).
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3.7. Functions of Y2H Gints
The data available in GeneCards entries suggested that the Y2H Gints could be allocated to 
four main groups based on functions: (1) synapses, channels and neurodevelopment: 
ATP6V1D, DLGAP3, GPM6B, INA, KCNAB2, OLFM1, PQLC1, SCOC, SNAP25, SRI 
and TPM4; (2) transcription, RNA processing, gene regulation, cell cycle and chromatin: 
CCNB1IP1, CUL1, ID2, PDE4DIP, PRKRA, PRPF38B, RPGRIP1L and ZNF418; (3) 
kinases and signaling: CSNK2B, MIF and RIIAD1; and (4) hematopoiesis, leukemia, 
cancer, blood plasma and platelets: ANKRD26, CT45A, FAM89B, FTH1 and KIAA1549L 
(formerly known as C11orf41). FAM89B and KIAA1549L showed their highest levels of 
protein expression in blood plasma and platelets and were therefore assigned to group 4. 
Several Gints have multiple functions, such that they could be assigned to multiple groups. 
GeneCards data indicate that all 27 Gints are expressed at detectable levels in human brain. 
Furthermore, eight Gints displayed their highest levels of expression in brain: ATP6V1D, 
DLGAP3, FTH1, GPM6B, INA, PRKRA, SNAP25 and SRI.
3.8. Bioinformatic analyses suggest GCOM1's involvement in CNS functions and other 
physiologic processes
To determine more convincingly that Gcom1 interactors, especially the novel Y2H genes, 
could be assigned to biologically relevant functional groups, we analyzed them further using 
Ingenuity Systems software (IPA) and other methods, in two ways, beginning in 2007. First, 
we analyzed our novel 27 Gcom1 interactors (narrowly defined Gints) from our Y2H studies 
as a group. Second, we combined our Y2H Gints with our immunologic GRIN1 interaction 
and with the broad GCOM1 interactome which includes: all GCOM1 proteins for which 
there are interactants in GeneCards and IPA. Specifically, GeneCards Gints (as of 1 January 
2016) included 16 for the gene symbol GCOM1, 32 for the Gup proteins (aka MYZAP) and 
24 for the Gdown proteins (aka POLR2M). As of 14 February 2017, these numbers have 
increased to 17, 68 and 27, respectively. Note that Gup and Gdown proteins may or may not 
also interact with Gcom proteins.
Fig. 4 depicts a network diagram (IPA Path Designer) using the broad GCOM1 interactome 
made by the Grow 3 algorithm with the command “Grow 3 molecules at a time to connect 
Gints with NSMF.” NSMF was chosen based upon its function in NMDA receptor mediated 
synaptonuclear signaling and neuronal migration (see Section 4.4). The network shows a 
moderate level of connectivity, suggesting likely biologic relevance. The orange lines 
(edges) indicate new connections predicted by Grow. Key signaling pathways shown involve 
ERK, CREB and NSMF. For example, the Gint CUL1 connects to ERK, which networks to 
the Gint INA, which links to NSMF. Another path to NSMF runs from the Gint RPGRIP1L 
to RPSA to RPS21 to FMR1, which links to NSMF. CUL1 also connects through RPS21 to 
RNA polymerase II (the 13th subunit of which is the GCOM1 protein Gdown1, aka 
POLR2M) to NSMF. Overall, the known and putative novel edges in Fig. 4 suggest the 
involvement of GCOM1 proteins in the glutamate system, in particular with the NMDA 
receptor via the GRIN1 subunit. It should be noted that the IPA software does not depict all 
known connections. For example, the GRIN1-INA interaction, which has been known since 
the year 2000 (Husi et al., 2000), does not have an edge in this network, but should. Another 
aspect which this IPA algorithm does not address is that many Gints can be shown to 
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network with other Gints through one or two intervening interacting genes from GeneCards. 
For example, the Gint OLFM1 interacts with the hub gene disrupted in schizophrenia 1 
(DISC1), two of whose interactors are AKAP9 (yotiao) and KALRN, both of which interact 
with the Gint GRIN1. Another example includes the following Y2H Gints (bold print): 
OLFM1 ↔ PAX3 ↔ ID2 ↔ ERBB2 ↔ UL1.
In a different Path Designer format called “Connect,” IPA produced a larger, more 
complicated network diagram (Supplementary Fig. 1), which also includes canonical 
pathways. This network reveals links to several neurologically relevant pathways, especially 
glutamate and calcium signaling, long-term potentiation, amyloid processing, SLE and 
Huntington's disease signaling, dopaminergic transmission and mTOR and ERK signaling. 
As with the Grow algorithm, the GCOM1 hub was connected to the ERK-NSMF hub, with 
GRIN1 interactions key to both pathways. Furthermore, in contrast to the Grow diagram, 
Supplementary Fig. 1 does show the GRIN1-INA interaction, suggesting a possible triple 
interaction, GCOM1 ↔ GRIN1 ↔ INA.
3.9. Demonstration of GCOM1-INA interaction by co-immunoprecipitation in a mammalian 
system
To determine whether the GCOM1-Gint interactions revealed in the yeast two-hybrid system 
might reflect physiologically relevant interactions in mammalian tissues, we performed co-
immunoprecipitation studies using adult rat brain protein preparations (RBP), anti-GCOM1 
primary antibodies and anti-Gint secondary antibodies. We hypothesized that internexin-α 
would be a prime candidate for a significant interaction with GCOM1 proteins in the 
mammalian CNS for reasons described above. In addition, INA is involved in NIFID, a form 
of fronto-temporal dementia (Cairns et al., 2004), and is therefore likely to be a clinically 
relevant interacting gene. Finally, INA is known to interact with the NMDA receptor (Husi 
et al., 2000).
Western blots of unprecipitated brain lysate (Fig. 5A–C, lanes 1) reveal the expected bands 
for GCOM1 and INA proteins, respectively: a 54 kDa Gup1 species and a 66 kDa INA 
species. (Three faster migrating INA species, especially the intense 40 kDa band, may 
represent proteolytic cleavage products derived from the major 499 aa isoform, UniProtKB 
Q16352.) Although these blots are not rigorously quantitative, it is evident that INA proteins 
show much higher levels of immunofluorescence than GCOM1 proteins in the 
unprecipitated samples and are therefore likely to be much more abundant. The Gcom1 and 
Gcom15 proteins were not detectable because only 20 μg of RBP were loaded in Fig. 5A, B, 
lanes 1. To demonstrate that our rabbit polyclonal, anti-peptide, anti-GCOM1 antibodies 
raised against Gcom1 amino acids T423-Q440 precipitate Gcom1 and other GCOM1 
proteins containing exons with epitopes present in the peptide, we precipitated RBP with 
these Ab and stained Western blots with the same antibody. Fig. 5A, lane 2, containing 
proteins precipitated from 400 μg RBP, shows intense immunofluorescence at the 54 kDa 
Gup1 position and less intense bands at 64 kDa and 105 kDa corresponding to Gcom1 and 
Gcom15, respectively. These GCOM1 protein bands and relative amounts are similar to 
what we have observed previously with rabbit anti-S23-E38 antibodies (Roginski et al., 
2008). Proteins not precipitated by the anti-GCOM1 Ab (Fig. 5A, lane 3) and IP proteins 
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pulled down by an anti-synaptophysin Ab (Fig. 5A; lane 4) show neither Gcom1 nor 
Gcom15. Trace amounts of Gup1 (in lane 3) may be due to sub-quantitative 
immunoprecipitation of the abundant Gup1 protein and/or “spillover” from loading lane 2. 
Therefore, Fig. 5A demonstrates that the anti-Gcom1 T423-Q440 antibodies precipitate 
several expected GCOM1 protein species which are present in the RBP preparation in a 
quantitative fashion and do not bind to proteins pulled down by anti-synaptophysin Ab.
A replicate Western blot (Fig. 5BCD) was used to determine whether anti-Gcom1 Ab can 
pull down INA bound to GCOM1 proteins. As in Fig. 5A, anti-T423-Q440 antibodies were 
employed for IP (lanes 1–3). However, due to the fact that the anti-INA Ab preparation is a 
rabbit polyclonal IgG, we could not use our rabbit anti-T423-Q440 to detect GCOM1 
protein bands in this experiment. Therefore, we designed a chicken anti-amino terminal Ab 
against residues S23-E38, which are common to Gcom1, Gcom15 and Gup1. For reasons 
that may be related to the epitopes present in the S23-E38 peptide or the accessibility of the 
cognate sequences in the mature GCOM1 proteins, this antibody preparation does not react 
as strongly with the IP GCOM1 proteins as the anti-T423-Q440 antibodies (Fig. 5B, lane 2, 
versus Fig. 5A, lane2). In fact, there appears to be more immunoreactive signal migrating at 
discrete molecular sizes in the unbound fraction (Fig. 5B, lane 3) than in the IP fraction 
(lane 2) with this antibody. A possible explanation for this phenomenon is that (a) the 
chicken anti-S23-E38 Ab binds more weakly to its target sequence and (b) the target 
sequence may be masked to different degrees in the various GCOM1 proteins. Also, during 
the mixing and binding step, some of the more abundant INA proteins may have bound to 
and formed complexes with GCOM1 proteins, which, due to conformational changes, were 
not brought down by the anti-T423-Q440 antibodies and therefore ended up in the unbound 
fraction. Interestingly, the band sizes in Fig 5B and D (yellow in merged image), lane 3, are 
about 40 kDa larger than the GCOM1 species bands in Fig. 5A lane 2. Therefore, it is 
possible that only some of the GCOM1-INA complexes may be precipitable by the anti-
T423-Q440 antibodies.
Fig. 5C (lane 2) reveals a robust signal from the ~50 kDa putative doublet INA band, 
strongly supporting an interaction of GCOM1 and INA proteins. We also observed a small 
signal from the 66 kDa INA species, although it is clearly not the predominant band. INA is 
not precipitated by anti-SYP Ab (negative control, lane 4), indicating that the observed co-IP 
is most likely due to a specific interaction with one or more of the GCOM1 proteins. The 
unbound fraction (Fig. 5C, lane 3) contains much more total INA immunofluorescence than 
the IP lane, most probably because INA proteins are much more abundant than GCOM1 
proteins. Therefore, only a fraction of the total INA proteome would be able to associate 
with the less abundant GCOM1 proteins. Moreover, INA had 36 interactants in GeneCards 
as of 2 November 2016; an updated value of 211 was found on 14 February 2017. Such an 
abundance of interacting genes would be expected to reduce the pool of INA proteins 
available to associate with GCOM1 proteins.
Fig. 6 addresses the same question as Fig. 5 using both preparations of anti-Gcom1 T423-
Q440 antibodies (GenScript rabbits 1585 and 1586), with chemiluminescent detection 
instead of fluorescent secondary antibodies. Another difference from Fig. 5 is that lower 
amounts of rat brain proteins were used for these immunoprecipitations. As a result, Fig. 6A 
Roginski et al. Page 11
Gene. Author manuscript; available in PMC 2018 June 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
shows that the predominant GCOM1 protein in the un-precipitated lysate (lane 1) is Gup1, 
migrating at 54 kDa. Fig. 6A again demonstrates that Gcom15 is a relatively low abundance 
protein, because 20 μg of RBP does not reveal a band at the 105 kDa position (lane 2). 
However, IP from 100 μg RBP clearly demonstrates efficient staining and IP of the Gcom15 
protein (bold arrow). Note that IP is more efficient by the antibodies from rabbit 1585 than 
from rabbit 1586. (This result may reflect differential loss of binding ability of the 1586 
antibodies as a result of transport or storage conditions.) Fig. 6B demonstrates co-IP of the 
66 kDa INA band (lane 3) by 1585 antibodies. No INA immunostaining is seen in lane 2 (no 
antibody control). As in Fig. 5, we observe a 66 kDa band in the unbound fraction (lane 4), 
indicating that co-IP is not quantitative, most likely because internexin-α protein levels 
greatly exceed those of GCOM1 proteins. We also performed the reverse co-IP using anti-
INA antibodies in an attempt to pull down GCOM1 proteins: Fig. 6C reveals a weak 
Gcom15 band (boxed, lane 3), which is not present in the flow-through and no antibody 
controls (lanes 4 and 2, respectively). Our finding of co-IP between rat Gcom15 and INA is 
strong evidence that these proteins can interact in the mammalian CNS.
4. Discussion
4.1. Our results encompass five major findings
(1) isolation of the ORFs of the largest GCOM1 cDNAs and proteins detected to date, 
Gcom15, from human and rat sources; (2) the demonstration in heterologous cells of co-IP 
of Gcom15 and the Grin1 subunit of the NMDA receptor; (3) the discovery of 27 genes 
(Gints) that interact with the Gcom1 protein in yeast two-hybrid screens; (4) roles for the 
GCOM1 combined proteins (especially Gcom15) in normal CNS function, neurologic 
disease and neuroprotection based upon the identities, known functions and human 
chromosomal locations and clustering of Gints; and (5) initial evidence for verification of 
the Gcom15-internexin-α protein–protein interaction in a mammalian system, rat brain 
proteins. In the sections to follow, we shall discuss the implications and ramifications of 
these findings, with particular emphasis on the functions they suggest for the GCOM1 
complex hub gene.
4.2. Significance and broader relevance of the Gcom15 transcripts and proteins
In our most recent publication (Roginski et al., 2008), we detected a GCOM1 protein in rat 
brain larger than any of the ORFs that we had cloned previously (Roginski et al., 2004). To 
confirm and extend this result to human brain, it was clearly necessary to isolate and express 
cDNAs capable of encoding this 105 kDa protein. Next, the demonstration of another 
combined GCOM1 protein displaying a novel splice between the upstream and downstream 
segments of the complex transcription unit, which continues the reading frame in both 
species tested thus far, would further support this model. Finally, we hypothesized that the 
large Gcom15 proteins would be biologically relevant, especially because our 2008 
immunoprecipitation studies suggested only a weak co-IP of transfected mouse NR1-1a 
protein by human Gcom1-HA. Therefore, the question as to which GCOM1 protein(s) was 
(were) responsible for co-IP of the GRIN1 subunit of the NMDA receptor awaited 
resolution.
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To shed light on this issue, and to generate cDNAs that would facilitate study of the 
respective proteins in heterologous cells, we cloned the hypothesized ORFs from both 
human and rat brain sources. This task proved difficult because of the length and high GC 
content of these mRNAs, as well as their lower abundance compared to other GCOM1 
mRNAs in the complex brain mRNA population. In fact, attempts to amplify the ORFs 
directly from rat brain polyadenylated RNA, i.e., by employing primer combinations from 
the 5′ and 3′ untranslated regions, were unsuccessful. Therefore, we cloned overlapping 
upstream and downstream products, which were joined as described (Results Section 3.1 and 
Fig. 1). The rat PCR products were able to be cloned using standard techniques because the 
upstream and downstream products cloned in orientations favorable for the reconstitution of 
the rat Gcom15 reading frame. However, this method did not work for the human ORF, 
because each of the human products cloned in only one orientation. Therefore we denatured 
and re-annealed a mixture of the overlapping upstream and downstream amplicons, followed 
by self-extension of the resulting upstream-downstream hybrid duplexes for several cycles. 
We successfully amplified the 765-codon Gcom15 ORF in toto from the reconstituted 
amplicon, using a second set of primers nested relative to the upstream (sense) primer of the 
5′ product and the downstream (antisense) primer of the 3′ product. Thus, we used atypical 
methods to clone the Gcom15 ORFs, especially human Gcom15. One might contend, 
therefore, that we created entities which do not occur naturally in their respective species. 
However, at least 3 lines of evidence argue in favor of the biological reality of Gcom15: (1) 
RNA data: mRNA species large enough to encode the human ORF have been detected by 
Northern blot analysis; at least 2 of these large mRNAs were revealed with both upstream 
(exons 1–6) and downstream (exons 21–23) probes (Roginski et al., 2004), suggesting that 
the exon 13/21a/22 splicing pattern occurs in vivo; (2) when expressed in heterologous cells, 
the cloned human and rat Gcom15 cDNAs generate stable proteins which have the same 
mobility in Western blots (105 kDa) as the Gcom15 species detected in rat brain (Roginski 
et al., 2008); and (3) both human and rat Gcom15 display co-IP with the mouse NMDA 
receptor subunit NR1-1a in heterologous cells (Fig. 3), consistent with our results observed 
in rat brain (Roginski et al., 2008). Such results would be unlikely if these proteins did not 
represent true biologic entities. Finally, Gcom15 may not be the only large GCOM1 protein 
larger than Gcom1. For example, the exon 13–exon 21a splice suggests the possibility of 
splicing to the shorter exon 21b, which would lead to an ORF comprised of exons 1–
10/12/13/21b/22/23 (608 aa). Another potential variant could incorporate the exon 22–exon 
25 splice observed in the Gdown2 transcript (Roginski et al., 2004), resulting in an ORF 
with exons 1–10/12/13/21a/22/25–28 (760 aa). Because of their distinct amino acid 
sequences, these hypothetical proteins might have different biological functions from 
Gcom15, though still be potentially capable of interacting with the NMDAR.
4.3. New insights into the complex gene model based on Gcom15
Other complex genes meeting the criteria that we established previously based on GCOM1 
(Roginski et al., 2004) have been reported, as have studies of more traditional genes with 
very large numbers of splice variants. The term “transcription induced chimeras” (TICs) was 
coined in 2006 to describe complex genes; these authors cited over a dozen examples 
(including GCOM1) for which they provided computational and experimental support (Parra 
et al., 2006). Another group (Hernandez-Sanchez et al., 2006) published detailed evidence 
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for chimeric tyrosine hydroxylase-insulin transcripts during early avian development. 
However, the hybrid transcripts were not detected in mouse embryos, suggesting that some 
complex genes may show species-specific regulation. Classic examples of “mega-splicing” 
are the neurexin genes (Rowen et al., 2002), which generate thousands of isoforms using 
multiple promoters and alternative splicing at up to 5 different positions in their pre-mRNAs. 
The GCOM1 gene employs both mechanisms to augment its proteome and could be part of a 
larger transcript including exons from two neighboring upstream genes (see Section 4.4). 
Our previous conservative estimate for the total number of Gup, Gdown and Gcom mRNA 
transcripts prior to the discovery of the Gcom15 splicing pattern (Roginski et al., 2004) was 
284. The recognition of the novel exon 13–exon 21a splice would increase this number at 
least by a factor of 2.
4.4. Functional implications of chromosomal sites of GCOM1 and Y2H Gints
Intriguingly, the genomic neighborhood surrounding GCOM1 on human chromosome 15 
from NEDD4 to ADAM10 (~2.9 Mb) includes several genes that encode functions that may 
be related to and possibly shed light on those of GCOM1. First and foremost, two genes 
located immediately upstream from and centromeric to GCOM1, TCF12 and CGNL1, are 
transcribed in the same direction (on the “plus” strand, towards the telomere) as GCOM1. 
The segment harboring these genes spans ~864 kb and could therefore constitute a 
megagene composed of 4 genes (recall that GCOM1 is formed from the upstream and 
downstream genes). If the same combinatorial mechanism that occurs in the GCOM1 
complex transcription unit were applied to the megagene, 15 groups of transcripts and 
proteins could be produced. Amazingly, TCF12, which is involved in ERK signaling and 
other pathways, is a transcription factor (like Gdown1). Among TCF12's interacting genes 
are the Y2H Gints ID2 and SRI. CGNL1 is a coiled-coil protein (as are Gcom1 and 
Gcom15) involved in tight cell–cell junctions (as is Gup1). NEDD4, a GeneCards Gint of 
both Gdown1 and Gup1, which is expressed in neural precursor cells and is involved in 
NOTCH signaling, is located ~1.6 Mb centromeric to GCOM1. NEDD4 lists the Y2H Gint 
CUL1 among its interacting genes. Finally, ADAM10, an α-secretase involved in 
Alzheimer's disease, lies ~1 Mb telomeric to GCOM1 and encodes a 748 aa type 1 
membrane protein, about the same size as Gcom15 (765 aa), which is also a putative type 1 
membrane protein.
Intriguingly, the cluster of 4 genes at human 9q34.3, OLFM1-NOTCH1-GRIN1-NSMF, 
three of which are Gints, strongly suggests nervous system roles for GCOM1, based on 
information in GeneCards. First, the Gints OLFM1, GRIN1 and NSMF all interact with 
INA. Second, OLFM1 also interacts with the Gints SNAP25 and GRIN1 and with KALRN, 
which interacts with the OLFM1-proximal genes GRIN1 and NOTCH1. KALRN also 
interacts with DISC1, which is an interactor of OLFM1. Finally, among the interactors of 
NOTCH1 are the Y2H Gints CUL1 and ATP6V1D and the GCOM1-proximal genes TCF12 
and ADAM10 on 15q. The finding of multiple interactions between GCOM1-interacting 
genes with each other and with neurologically related genes, especially in clusters on human 
chromosomes 15 and 9, appears to be nonrandom and may facilitate coordinate regulation.
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4.5. Possible roles of GCOM1-NMDAR interaction and implications for neuroprotection
Our demonstration of bidirectional co-IP between human Gcom15 and mouse NR1-1a 
proteins strongly suggests that this interaction may also occur between the orthologous 
proteins in their respective species, e.g., human GCOM1 and human GRIN1, due to the high 
degree of sequence conservation of the GCOM1 and GRIN1 genes in mammalian species. 
The finding of a GCOM1-GRIN1 interaction by co-IP is also consistent with our previous 
results in rat CNS neuronal cultures which suggested an interaction between these genes 
(Roginski et al., 2008), as well as our finding of enrichment of rat Gcom15 in the plasma 
membrane fraction, a location necessary for a role in synaptic function. Although further 
studies will be necessary to elucidate the details of the GCOM1-GRIN1 interaction in vivo, 
the likelihood of its existence led us to ask two broad questions about its possible role in the 
CNS: (1) Do GCOM1 proteins participate in a subset of NMDA receptor complexes, and, if 
so, might they modulate the functions of NMDA receptors? (2) Could stimulation of 
NMDARs lead to changes in neuronal gene expression by a novel pathway that transduces 
the glutamate signal from the NMDAR via the GRIN1 subunit through GCOM1 protein(s) 
to downstream effector molecules?
Regarding the first question, GCOM1 proteins may alter the calcium permeability of 
NMDARs. In a preliminary study, one of us (RSR) has shown that pre-treatment of rat 
neuronal cultures with anti-GCOM1 antibodies (S23-E38 of the Gcom1/Gcom15 amino acid 
sequence) reduced both the rate of rise and peak values of Ca2+ influx in response to applied 
NMDA (Roginski, 2007). Based on our data in this paper, it appears probable that the effect 
on calcium entry may result primarily from binding of the anti-GCOM1 antibodies to 
Gcom15 proteins, which could disrupt Gcom15's interaction with the GRIN1 subunit. 
Decreased calcium entry into neurons is also a plausible explanation for the protection 
against NMDA toxicity afforded by anti-GCOM1 antibodies (Roginski et al., 2008). Tying 
these several threads together, we speculate that GCOM1 combined proteins may participate 
in a subset of NMDA receptor complexes (NRCs) and thereby modulate NMDAR-mediated 
Ca2+ influx into neurons. It remains to be determined whether Gcom proteins are associated 
primarily with synaptic or extra-synaptic NRCs. By avoiding strategies that directly inhibit 
NMDARs (which have failed in clinical trials), we suggest that GCOM1 proteins may 
provide attractive targets to investigate as one component of a combination approach for 
achieving clinically useful neuroprotection.
The answer to the second question may also have implications for neuroprotective strategies 
in at least two ways. First, the Gcom15 protein contains the same downstream carboxy-
terminal exons (21a/22/23) as in the Gdown1 protein, which is the 13th subunit of RNA 
polymerase II (Hu et al., 2006). This might effect changes in gene expression as follows. 
Stimulation of NMDARs complexed with Gcom15 might result in the proteolytic cleavage 
of fragments derived from Gcom15 and/or other Gints (such as INA). Such fragments could 
be transported to the nucleus wherein they might affect transcription by competition with 
Gdown1 already bound to RNAP2, thus interfering with the functionality Gdown1 
(Espinosa, 2012). A second mode would invoke recruitment of Gints that interact with 
Gcom15 (and possibly Gcom1) after activation of NMDAR-GCOM1 synapses (see Section 
4.7).
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4.6. Yeast two-hybrid GCOM1 interacting genes: consistency with hypotheses and 
implications for GCOM1 functions
At least two thirds of the protein–protein interactions revealed in Y2H screens can be 
verified in mammalian or other eukaryotic organisms. For example, Zoghbi and colleagues 
verified 83% of their Y2H interactions in mammalian cells (Lim et al., 2006). Therefore, it 
is likely that most of our Y2H Gints are capable of physiologically important interactions 
with GCOM1 proteins. Nevertheless, such likely PPIs need to be verified by other means. 
Pending such verification, however, we may draw some tentative inferences about the roles 
of GCOM1 proteins based upon the classes of genes revealed in our Y2H screens. First of 
all, we screened an adult brain cDNA library because the brain expresses the largest fraction 
of the proteome. Furthermore, we knew from EST databases and our prior work (Roginski et 
al., 2004) that GCOM1 expresses exons from the entire complex gene in the brain, i.e., the 
combined, upstream and downstream genes, such that the CNS has a larger number of 
GCOM1 proteins with which interactions might occur. Therefore, it is not surprising that all 
of the Gints are expressed in brain and that 8 Gints show their highest levels of tissue-
specific expression in the brain (GeneCards). Second, the Y2H Gints could easily be 
assigned to groups which are consistent with our hypotheses, especially the role in synaptic 
function of NMDA receptors and possible regulation of neuronal gene expression. Third, 
bioinformatic analyses revealed interaction networks indicative of several important 
neurophysiologic pathways. Fourth, the observation that several pairs of our Y2H Gints and 
the larger group of GCOM1 interacting genes (which includes the Gcom1/Y2H + Gup1/
MYZAP + Gdown1/POLR2M Gints) are located close together on specific human 
chromosomes may also suggest functional significance, consistent with insights gleaned 
from IPA networks. Also of note, we did not expect to detect the GRIN1 gene in our screens 
because the yeast two-hybrid system inherently favors the identification of soluble (i.e., 
cytosolic and nuclear) rather than membrane-associated proteins. Because of this constraint, 
Gcom1's 27 Y2H Gints represent a lower limit on the number of interactors for this protein. 
Tallying the GCOM1 interacting genes (for Gcom, Gup and Gdown proteins) from all 
sources (Section 3.8), we estimate a lower limit of 140 for the number of genes in the 
GCOM1 interactome.
4.7. GCOM1-INA protein–protein interaction in mammalian CNS
One of the likely functions of the GCOM1 proteins is a role in glutamatergic 
neurotransmission, mediated by an interaction with the GRIN1 subunit of the NMDAR. This 
hypothesis is bolstered by the Gene Ontology section of the GCOM1 entry in GeneCards, 
which lists intracellular signal transduction as the sole biological process. Additional roles in 
normal neurologic function and diseases are suggested by sequence similarities between 
Gcom1/Gcom15 and INA and LCA5 proteins, which are involved in neurologic diseases. 
How might the GCOM1 combined proteins play a role in signal transduction? We propose 
that activation of NRCs results in cleavage of fragments from GCOM1 proteins (most 
probably Gcom15) associated therewith. Such fragments may bind to internexin-α to 
facilitate transfer of these complexes to the nucleus (Fig. 7). There, the fragments of 
GCOM1 proteins, which contain partial sequences of Gdown1/POLR2M, may alter 
transcriptional programs, e.g., by displacing Gdown1 already bound to RNA polymerase II 
or by interacting with other transcription-relevant Gints expressed in the nucleus, such as the 
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Y2H Gints PRPF38B, RIIAD1 and ID2 and/or the GeneCards Gints TANK, NFKB1A and 
NFKB1/2. Precedent exists for such a role of internexin-α: INA fragments associate with 
NSMF to facilitate the nuclear transit of signals initiated at synaptic (but not extrasynaptic) 
NMDARs. Once inside the nucleus, NSMF induces the dephosphorylation of CREB 
proteins (Karpova et al., 2013). Therefore, the Gcom15-internexin-α interaction might be 
the entry point to a previously unrecognized, biologically important pathway, which may 
play a role in neuroprotection (Roginski et al., 2008).
In summary, we have cloned, expressed and performed immunologic experiments with 
Gcom15 cDNAs and proteins from two mammalian species, demonstrating that Gcom15 is 
the most likely candidate responsible for the GCOM1-GRIN1 interaction we observed 
previously. These studies lend further support to the complex gene model of the GCOM1 
gene. We have expanded our knowledge of the interactome of the GCOM1 gene by yeast 
two-hybrid screens using cDNAs corresponding to the Gcom1 protein, revealing 27 novel 
interacting genes, termed Gints, which strengthens our conclusion that GCOM1 is a hub 
gene. Furthermore, GCOM1's status as a hub gene suggests many areas for future study with 
likely clinical relevance to neurodegenerative and neuropsychiatric disorders. Finally, 
evidence supporting the Y2H interaction of Gcom15 with internexin-α was obtained in a 
mammalian system. Owing to the fact that INA also interacts with the key GRIN1 subunit of 
the NMDA receptor, our findings suggest the existence of a novel pathway, the details of 
which should be investigated.
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GRINL1A
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Fig. 1. 
Hybridization-extension amplification of overlapping human Gcom15 PCR products to 
reconstitute the complete ORF. (A) Extension of hybrid template formed by annealing of 
overlapping upstream (from 5′ product) and downstream (from 3′ product) strands 
followed by self-primed extension (filled in bases). Of the four possible hybridization 
products, only the 5′ sense strand/3′ anti-sense strand hybrid can be converted to double-
stranded DNA in the self-extension phase. After addition of nested primers targeting the 5′ 
and 3′ untranslated regions, only this template, containing the entire, reconstructed ORF 
plus segments of the 5′ and 3′ untranslated regions, can be amplified. (B) Agarose gel 
electrophoresis of human and rat Gcom15 cDNAs. 1, Human Gcom15 amplicon containing 
the complete ORF plus segments of the 5′ and 3′ non-coding regions, 2.3 kb. 2, 1 kb DNA 
ladder. 3 and 4, rat Gcom15 cDNA plasmids, both digested with BglII and SpeI, containing 
overlapping 5′ and 3′ segments, respectively. Rat Gcom15 PCR products were clonable in 
the proper orientations to permit reconstitution of the ORF by combining the A fragment 
from the plasmid in lane 3 with the B fragment from the plasmid in lane 4.
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Fig. 2. 
Human GCOM1 combined proteins. (A) Exon diagrams of human Gcom1 (AY207007) and 
Gcom15 (JF419331) cDNAs, showing conceptually how Gcom15 can be derived from 
Gcom1 by splicing exon 21a between exons 13 and 22. SP, signal peptide. M, putative 
membrane spanning region. Dots, consensus asparagine-linked glycosylation sites. (B) 
Space-filling model of human Gcom15 protein from Phyre software (Jmol).
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Fig. 3. 
Expression, immunoprecipitation and co-immunoprecipitation of GCOM1 and GRIN1 
proteins in HEK293 cells. Human and rat Gcom15 and mouse NR1-1a cDNAs were 
transfected as described in Methods. Anti-Gcom1 S23-E38 (rabbit polyclonal antibody) and 
anti-NR1 SC-1467 (goat polyclonal antibody) were used for detection (IB) and 
immunoprecipitation (IP).
(A) IP with anti-GCOM; (B) IP with anti-NR1.
Upper panels. Detection of Gcom15 and NR1 immunoreactivity. The human and rat 
Gcom15 proteins both migrate as 105 kDa bands. The NR1 subunit migrates at 120 kDa. 
Note that intensity levels of NR1 immunoreactive bands are greater in the presence of co-
transfected Gcom15 proteins. GAPDH loading controls (not shown) indicated that equal 
amounts of transfected cell proteins were electrophoresed and transferred.
Lower panels. Co-immunoprecipitation. (A) NR1 immunoreactivity is detected in the 
presence of co-transfected human and rat Gcom15 cDNAs/proteins. (B) Gcom15 
immunoreactivity is detected in the presence of co-transfected human (but not rat) cDNA/
protein.
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Fig. 4. 
Network analysis (IPA Path Designer, Grow 3) incorporating gene symbols of the broad 
GCOM1 interactome. The program predicts novel possible connections (orange arrows) and 
a putative interaction between the GCOM1 and NSMF hubs. As discussed in the text, not all 
known interactions are included in the diagram. (For interpretation of the references to color 
in this figure legend, the reader is referred to the web version of this article.)
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Fig. 5. 
Immunoprecipitation with anti-GCOM1 antibody reveals co-IP of internexin-α. Replicate 
blots (A and BCD) were loaded, immunoprecipitated (IP), stained with primary and 
secondary antibodies and detected at appropriate wavelengths with the Odyssey system (Li-
Cor) as follows. Lane identities: 1, Total rat brain protein lysate (RBP), 20 μg. 2, Proteins IP 
from 400 μg RBP with anti-Gcom1 T423-Q440 Ab (GenScript rabbit 1586). 3, Flow 
through from 400 μg RBP IP with anti-Gcom1 T423-Q440. 4, Proteins IP from 400 μg RBP 
with anti-synaptophysin Ab (mouse monoclonal antibody; Millipore MAB329). 5, Size 
standards (Li-Cor fluorescent and Bio-Rad pre-stained). Staining: Primary antibodies: (A) 
rabbit anti-Gcom1 T423-Q440; (B) chicken anti-Gcom1 N-terminus S23-E38 (GenScript 
SC1492); (C) anti-INA (rabbit polyclonal antibody; Millipore AB5354). Secondary 
antibodies (all Li-Cor): (A) goat anti-rabbit IgG IRDye 680RD; (B) donkey anti-chicken IgG 
IRDye 680RD; (C) goat anti-rabbit IgG IRDye 800CW. (D) merged images of B and C. 
Note that the ~50 kDa band in Fig. 5B, lane 4 (anti-SYP IP proteins stained with chicken 
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anti-Gcom1 S23-E38 Ab) is probably an artifact because no immunoreactivity is present in 
Fig. 5A, lane 4.
Roginski et al. Page 25
Gene. Author manuscript; available in PMC 2018 June 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 6. 
Co-immunoprecipitation of GCOM1 and INA proteins in heterologous cells. (A) Control IP 
of rat brain lysate (100 μg; lanes 3–6 and 7–10) with increasing amounts (1 μL to 10 μL) of 
two different rabbit polyclonal anti-Gcom1 antibody preparations (from rabbits 1585 and 
1586, respectively). Lanes: 1, Molecular size standards. 2, rat brain lysate 20 μg. The 
predominant GCOM1 protein detected under these conditions is Gup1 (54 kDa). The intense 
bands migrating at ~50 and 25 kDa in lanes 3–10 are from IgG heavy and light chains, 
respectively. (B) IP of rat brain lysate (100 μg) with anti-Gcom1 antibody (rabbit 1585; 10 
μL) stained with anti-INA antibody (1:500 dilution). Lanes: 1, input brain lysate. 2, negative 
control IP without anti-Gcom1 Ab. 3, IP with anti-Gcom1 Ab. 4, flow-through of unbound 
wash from lane 3 sample. The expected INA band is 66 kDa (boxed). (C) Same lane 
assignments as in panel B, except IP of brain lysate with anti-INA Ab and probed with anti-
Gcom1 antibody. The rectangular box includes the 105 kDa position, which is the size of the 
faint Gcom15 protein band in lane 3 (see text). The predominant GCOM1 protein visible in 
lane 1 is Gup1 migrating at its expected size of 54 kDa. As in panel A, the low abundance 
Gcom1 and Gcom15 proteins are not seen in lane 1. Owing to the fact that this MW overlaps 
the IgG heavy chain position (~50 kDa) in lane 3, it is not possible to assess co-IP of INA 
and Gup1 proteins.
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Fig. 7. 
Proposed linear pathway based on interactions of GRIN1, GCOM1 and INA. The diagram 
illustrates one of the two hypothetical ways (see Sections 4.5 and 4.7) in which a synaptic 
signal that targets the NMDA receptor-GCOM1 complex may be transduced to the neuronal 
nucleus: the signal would travel from the NMDAR (via the GRIN1 subunit) through 
GCOM1 (most likely via the Gcom15 protein) to the neuronal intermediate filament protein 
internexin-α (INA). Because INA also is known to interact with GRIN1 and three of the 
GRIN2 subunits, the second hypothetical pathway (not shown) postulates a 3-way 
interaction of the NMDAR, GCOM1 proteins and INA which may transduce the signal using 
the same or different downstream effectors as the linear pathway.
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Table 2
Human chromosome sites of GCOM1 Y2H Gints.
Gene symbol Description Chromosome band Start base
1 ANKRD26 Ankyrin repeat domain 26 10p12.1 26,991,914
2 ATP6V1D ATPase, H+ transporting, lysosomal 34 kDa, V1 subunit D 14q23.3 67,294,371
3 CCNB1IP1 Cyclin B1 interacting protein 1, E3 ubiquitin protein ligase 14q11.2 20,311,368
4 CSNK2B Casein kinase 2, beta polypeptide 6p21.33 31,655,236
5 CT45A3 Cancer/testis antigen family 45, member A3 Xq26.3 135,759,846
6 CUL1 Cullin 1 7q36.1 148,697,914
7 DLGAP3 Discs large homolog-associated protein 3 1p34.3 34,865,436
8 FAM89B Family with sequence similarity 89, member B 11q13.1 65,572,349
9 FTH1 Ferritin, heavy polypeptide 1 11q12.3 61,959,718
10 GPM6B Glycoprotein M6B Xp22.2 13,770,943
11 ID2 Inhibitor of DNA binding 2, dominant negative HLH protein 2p25.1 8,678,845
12 INA Internexin neuronal intermediate filament protein, alpha 10q24.33 103,277,163
13 KCNAB2 Potassium channel, voltage gated subfamily A regulatory beta subunit 2 1p36.31 5,991,466
14 KIAA1549L Chromosome 11 open reading frame 41; KIAA1549-like 11p13 33,542,072
15 MIF Macrophage migration inhibitory factor (glycosylation-inhibiting factor) 22q11.23 23,894,004
16 OLFM1 Olfactomedin 1 9q34.3 135,075,243
17 PDE4DIP Phosphodiesterase 4D interacting protein 1q21.2 148,808,181
18 PQLC1 PQ loop repeat containing 1 18q23 79,902,420
19 PRKRA Protein kinase, interferon-inducible double stranded RNA dependent 2q31.2 178,431,414
20 PRPF38B Pre-mRNA processing factor 38B 1p13.3 108,692,310
21 RIIAD1 Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 1q21.3 151,710,433
22 RPGRIP1L RPGRIP1-like 16q12.2 53,597,683
23 SCOC Short coiled-coil protein 4q31.1 140,257,286
24 SNAP25 Synaptosomal-associated protein, 25 kDa 20p12.2 10,218,694
25 SRI Sorcin 7q21.12 88,205,115
26 TPM4 Tropomyosin 4 19p13.12 16,067,021
27 ZNF418 Zinc finger protein 418 19q13.43 57,921,884
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